NCT03416296

Completed

Role of Ultrasound in Diagnosis of Placenta Previa and MAP

Aljazeera Hospital Source

Compare

Other study identifiers

Sponsor study identifier

placenta

Study Type

observational

Actual enrollment (reported)

90

Locations

1 country

Sites

1

Timeline

Study Start

March 15, 2018

Actual (reported)

Primary Completion

June 10, 2019

Actual (reported)

Study Completion

December 20, 2019

Actual (reported)

Brief Summary

Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 90 participants
Study completion date: December 20, 2019
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
January 24, 2018
Actual (reported)
First Posted
January 31, 2018
Actual (reported)
Study Start
March 15, 2018
Actual (reported)
Primary Completion
June 10, 2019
Actual (reported)
Study Completion
December 20, 2019
Actual (reported)

Last Updated: September 16, 2021
Status Verified: September 2021
Last Update Submitted: September 15, 2021

Conditions

Morbidly Adherent Placenta

Outcome Measures

Primary Outcomes (1)

number of participants who will be diagnosed to have normal placenta or placenta previa or morbidly adherent placenta by US
within 6 weeks

Study Arms (2)

normal placenta

TA , TV ,TP us

placenta previa and MAP

TA,TV.TP us

Eligibility Criteria

Age20 Years - 43 Years

Sexfemale(Gender-based eligibility)

Gender Eligibility Detailspregnant females with GA above 30 weeks

Healthy VolunteersYes

Age GroupsAdult (18-64)

Sampling MethodProbability Sample

Study Population

pregnant females with previous cs will be subjected to US to assess placental location and MAP

You may qualify if:

Sponsors & Collaborators

National Research Centre, Egypt
Othercollaborator
Aljazeera Hospital
Otherlead
Cairo University

Study Sites (1)

Algazeerah

Giza, Egypt

Biospecimen

Retention: SAMPLES WITHOUT DNA

uterus in case of hysterectomy after cesarean hysterectomy

MeSH Terms

Conditions

Placenta Accreta

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Study Officials

Mahmoud Alalfy
Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
PRINCIPAL INVESTIGATOR

Enrollment

90 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: OTHER
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital

Study Record Dates

First Submitted

January 24, 2018

First Posted

January 31, 2018

Study Start

March 15, 2018

Actual (reported)

NCT03976453

Psychological Outcome of Women With Morbidly Adherent Placenta Following Hystrectomy

Completed

NCT07520201

Comparison Between 3 Conservative Surgeries for Placenta Accreta Spectrum

Not ApplicableRecruiting

NCT04866888

Placenta Accreta Spectrum Outcome After Uterine Conservation

Not ApplicableRecruiting

NCT05307016

Morbidly Adherent Placenta, Diagnosis and Proper Management

Unknown

NCT04229953

Accuracy of Three /Four-dimensional Ultrasound in Diagnosing Placenta Accreta Spectrum

Unknown

NCT04938050

Diagnostic Accuracy of a Specialized Pro Forma in Assessing Morbidly Adherent Placenta With Correlation to Intra-operative Findings

Unknown

pregnant ladies with previous cesarean sections

GA above 30 weeks

You may not qualify if:

Primigravida patients
GA below 30 weeks

Contact the study team to confirm eligibility.

Othercollaborator

Primary Completion

June 10, 2019

Actual (reported)

Study Completion

December 20, 2019

Actual (reported)

Last Updated

September 16, 2021

Record last verified: 2021-09

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT03416296
Data provider: ClinicalTrials.gov
Source updated: 2021-09-16
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:40:15 UTC

Locations

EG(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

normal placenta

placenta previa and MAP

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations